21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA
Introduction: Sentinel lymph node biopsy (SLNB) is a standard procedure at the OncologyInstitute of Vojvodina since 1999 and during this period we have done more than 1700 biopsies. The aim of this study was to present our results in SLNB in breast cancer surgery. Materials and methods: This retr...
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Association of medical doctors Sanamed Novi Pazar
2021-05-01
|
Colecção: | Sanamed |
Assuntos: | |
Acesso em linha: | http://www.sanamed.rs/OJS/index.php/Sanamed/article/view/471/253 |
_version_ | 1827337089734148096 |
---|---|
author | Selakovic Vladimir Ranisavljevic Milan Lukic Dejan Djuric Mladen |
author_facet | Selakovic Vladimir Ranisavljevic Milan Lukic Dejan Djuric Mladen |
author_sort | Selakovic Vladimir |
collection | DOAJ |
description | Introduction: Sentinel lymph node biopsy (SLNB) is a standard procedure at the OncologyInstitute of Vojvodina since 1999 and during this period we have done more than 1700 biopsies. The aim of this study was to present our results in SLNB in breast cancer surgery.
Materials and methods: This retrospective study was performed at the Department for Surgical Oncology at the Vojvodina Institute of Oncology in the period from January 1999 to December 2019. The study included 1762 patients who had undergone SLNB. The mean duration of the follow-up period was 121.89 months. All patients were women with clinically T1-2N0-1M0 breast cancer. Preoperatively, all patients were administered dual contrast media, radiotracer, and blue dye.
Results: The majority of tumors were T1c (955 (54.18%). The mean number of extirpated sentinel lymph nodes (SLN) in both groups was 1.84. In 199 (36.72%) patients SLN was the only metastatic lymph node in the axilla. Micro metastases were found in 113 (21.03%) patients. The overall diagnostic accuracy of SLNB was 96%.
Conclusion: Axillary SLN can serve as a reliable predictor of negativity of other ipsilateral axillary nodes. Micro metastases in the SLN are not an indication for complete axillary lymph node dissection. |
first_indexed | 2024-03-07T18:44:52Z |
format | Article |
id | doaj.art-d5ed04f9583c44848077f48351294a92 |
institution | Directory Open Access Journal |
issn | 1452-662X 2217-8171 |
language | English |
last_indexed | 2024-03-07T18:44:52Z |
publishDate | 2021-05-01 |
publisher | Association of medical doctors Sanamed Novi Pazar |
record_format | Article |
series | Sanamed |
spelling | doaj.art-d5ed04f9583c44848077f48351294a922024-03-02T03:04:19ZengAssociation of medical doctors Sanamed Novi PazarSanamed1452-662X2217-81712021-05-01161656910.24125/sanamed.v16i1.47121 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINASelakovic Vladimir0Ranisavljevic Milan1Lukic Dejan2Djuric Mladen3Oncology Institute of Vojvodina, Department for operative oncology, Novi Sad, Serbia1. Oncology Institute of Vojvodina, Department for operative oncology, Novi Sad, Serbia; 2. Medical faculty of Novi Sad, University of Novi Sad, Novi Sad, Serbia1. Oncology Institute of Vojvodina, Department for operative oncology, Novi Sad, Serbia; 2. Medical faculty of Novi Sad, University of Novi Sad, Novi Sad, Serbia Oncology Institute of Vojvodina, Department for operative oncology, Novi Sad, SerbiaIntroduction: Sentinel lymph node biopsy (SLNB) is a standard procedure at the OncologyInstitute of Vojvodina since 1999 and during this period we have done more than 1700 biopsies. The aim of this study was to present our results in SLNB in breast cancer surgery. Materials and methods: This retrospective study was performed at the Department for Surgical Oncology at the Vojvodina Institute of Oncology in the period from January 1999 to December 2019. The study included 1762 patients who had undergone SLNB. The mean duration of the follow-up period was 121.89 months. All patients were women with clinically T1-2N0-1M0 breast cancer. Preoperatively, all patients were administered dual contrast media, radiotracer, and blue dye. Results: The majority of tumors were T1c (955 (54.18%). The mean number of extirpated sentinel lymph nodes (SLN) in both groups was 1.84. In 199 (36.72%) patients SLN was the only metastatic lymph node in the axilla. Micro metastases were found in 113 (21.03%) patients. The overall diagnostic accuracy of SLNB was 96%. Conclusion: Axillary SLN can serve as a reliable predictor of negativity of other ipsilateral axillary nodes. Micro metastases in the SLN are not an indication for complete axillary lymph node dissection.http://www.sanamed.rs/OJS/index.php/Sanamed/article/view/471/253breast cancersentinel lymph nodecomplete axillary lymph node disection |
spellingShingle | Selakovic Vladimir Ranisavljevic Milan Lukic Dejan Djuric Mladen 21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA Sanamed breast cancer sentinel lymph node complete axillary lymph node disection |
title | 21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA |
title_full | 21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA |
title_fullStr | 21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA |
title_full_unstemmed | 21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA |
title_short | 21 YEARS AFTER INTRODUCING SENTINEL LYMPH NODE BIOPSY IN CLINICAL PRAXIS AT THE ONCOLOGY INSTITUTE OF VOJVODINA |
title_sort | 21 years after introducing sentinel lymph node biopsy in clinical praxis at the oncology institute of vojvodina |
topic | breast cancer sentinel lymph node complete axillary lymph node disection |
url | http://www.sanamed.rs/OJS/index.php/Sanamed/article/view/471/253 |
work_keys_str_mv | AT selakovicvladimir 21yearsafterintroducingsentinellymphnodebiopsyinclinicalpraxisattheoncologyinstituteofvojvodina AT ranisavljevicmilan 21yearsafterintroducingsentinellymphnodebiopsyinclinicalpraxisattheoncologyinstituteofvojvodina AT lukicdejan 21yearsafterintroducingsentinellymphnodebiopsyinclinicalpraxisattheoncologyinstituteofvojvodina AT djuricmladen 21yearsafterintroducingsentinellymphnodebiopsyinclinicalpraxisattheoncologyinstituteofvojvodina |